Gland Pharma Ltd - 543245 - Clarification sought from Gland Pharma Ltd
The Exchange has sought clarification from Gland Pharma Ltd on August 9, 2023, with reference to Movement in Volume.The reply is awaited.09-08-2023
Gland Pharma Ltd - 543245 - Clarification sought from Gland Pharma Ltd
The Exchange has sought clarification from Gland Pharma Ltd on August 9, 2023, with reference to Movement in Volume.The reply is awaited.Trade Spotlight | Your game plan for Gland Pharma, Indian Bank, Manappuram Finance today
Gland Pharma has formed long bullish candlestick pattern with long lower shadow on the daily charts, indicating buying at lower levels, after a day of Dojj candlestick pattern formation.Gland Pharma Ltd - 543245 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for financial year ended 31st March 2023Gland Pharma Ltd - 543245 - Reg. 34 (1) Annual Report.
Annual Report for the financial year ended 31st March 2023Gland Pharma Ltd - 543245 - Notice Of The 45Th Annual General Meeting Of The Company To Be Held On Thursday, 31St August 2023 At 11:00 AM (VC/OAVM)
Notice of the 45th Annual General Meeting of the Company to be held on Thursday, 31st August 2023 at 11:00 AM (VC/OAVM)Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Unaudited Financial Results for the quarter ended June 30,2023Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings Call for the quarter ended June 30, 2023Gland Pharma Results Earnings Call for Q1FY24
Conference Call with Gland Pharma Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication intimating the Shareholders that the 45th Annual General Meeting of the Company will be held on Thursday, August 31, 2023 at 11:00 AM (IST) through Video Conferencing / Other Audio Visual Means.Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Q1FY24 Financial Results